YW1128 is primarily utilized in the field of biomedical research, particularly in studies focused on cancer therapy. It is known for its role as an inhibitor that targets specific pathways involved in tumor growth and proliferation. Researchers employ YW1128 to investigate its potential in reducing the viability of cancer cells and enhancing the efficacy of existing treatments. Additionally, it is used in preclinical models to evaluate its impact on tumor regression and to understand its mechanism of action at the molecular level. This compound is also explored for its potential to minimize side effects associated with conventional therapies, making it a promising candidate for future therapeutic applications.